ARCHIVES

NCI Proposes Moving Organ Systems coordinating Center Activities In House, Dispersing Grants

This article is from The Cancer Letter archive.

Vol. 13 No. 40 | October 16, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

November 22, 2013

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012